| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |